GB9106894D0 - Conjugate compounds of polymers with other organic molecular entities - Google Patents

Conjugate compounds of polymers with other organic molecular entities

Info

Publication number
GB9106894D0
GB9106894D0 GB919106894A GB9106894A GB9106894D0 GB 9106894 D0 GB9106894 D0 GB 9106894D0 GB 919106894 A GB919106894 A GB 919106894A GB 9106894 A GB9106894 A GB 9106894A GB 9106894 D0 GB9106894 D0 GB 9106894D0
Authority
GB
United Kingdom
Prior art keywords
polymers
molecular entities
organic molecular
conjugate compounds
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB919106894A
Other versions
GB2244491A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCHACHT ETIENNE H
Original Assignee
SCHACHT ETIENNE H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCHACHT ETIENNE H filed Critical SCHACHT ETIENNE H
Publication of GB9106894D0 publication Critical patent/GB9106894D0/en
Publication of GB2244491A publication Critical patent/GB2244491A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/338—Polymers modified by chemical after-treatment with inorganic and organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/334—Polymers modified by chemical after-treatment with organic compounds containing sulfur
GB9106894A 1990-04-02 1991-04-02 Conjugate compounds of polymers with other organic molecular entities. Withdrawn GB2244491A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909007384A GB9007384D0 (en) 1990-04-02 1990-04-02 Coupling between polymers and other organic molecular entities utilising thiol-specific reactive groups

Publications (2)

Publication Number Publication Date
GB9106894D0 true GB9106894D0 (en) 1991-05-22
GB2244491A GB2244491A (en) 1991-12-04

Family

ID=10673725

Family Applications (2)

Application Number Title Priority Date Filing Date
GB909007384A Pending GB9007384D0 (en) 1990-04-02 1990-04-02 Coupling between polymers and other organic molecular entities utilising thiol-specific reactive groups
GB9106894A Withdrawn GB2244491A (en) 1990-04-02 1991-04-02 Conjugate compounds of polymers with other organic molecular entities.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB909007384A Pending GB9007384D0 (en) 1990-04-02 1990-04-02 Coupling between polymers and other organic molecular entities utilising thiol-specific reactive groups

Country Status (3)

Country Link
AU (1) AU7563891A (en)
GB (2) GB9007384D0 (en)
WO (1) WO1991015242A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0683676A4 (en) * 1993-02-02 1998-09-30 Neorx Corp Directed biodistribution of small molecules.
EP0622394A1 (en) * 1993-04-30 1994-11-02 S.A. Laboratoires S.M.B. Reversible modification of sulfur-containing molecules with polyalkylene glycol derivatives and their use
US20010055581A1 (en) 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US5770645A (en) * 1996-08-02 1998-06-23 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US7229841B2 (en) 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
JP2008504216A (en) 2003-12-02 2008-02-14 サイトイミューン サイエンシズ インコーポレイテッド Methods and compositions for the production of monoclonal antibodies
CA2706700A1 (en) 2007-11-08 2009-05-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5130599B2 (en) * 1972-09-07 1976-09-01
SE431758B (en) * 1977-03-04 1984-02-27 Pharmacia Fine Chemicals Ab AS THE USE OF THE TIOLATION REAGENT OR BERRY MATRIX FOR ENZYMERS DERIVATIVE OF A SH GROUPING POLYMER
SE448631B (en) * 1978-04-28 1987-03-09 Toyo Jozo Kk DISULFIDE ASSOCIATION OF A SAR-S REPLACTER REACTIVITY
EP0040506B1 (en) * 1980-05-21 1986-08-20 Teijin Limited Reactive polymer and process for the preparation thereof
JPS57130911A (en) * 1981-02-06 1982-08-13 Kao Corp Second composition for permanent wave treatment
JPS59159828A (en) * 1983-03-02 1984-09-10 Teijin Ltd Reactive polymer and its production
JPS59215321A (en) * 1983-05-23 1984-12-05 Sumitomo Chem Co Ltd Reactive polymer having bound bifunctional ligand
CA1223222A (en) * 1984-02-22 1987-06-23 Nanibhushan Dattagupta Immobilized nucleic acid-containing probes
US4886755A (en) * 1984-12-07 1989-12-12 Bioprobe International, Inc. Preparation of polymeric thiol gels for covalent bonding of biologically active ligands
FR2601680B1 (en) * 1986-07-15 1990-06-29 Sanofi Sa PROTEIN SYNTHESIS INHIBITOR, ISOLATION METHOD, USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2605237B1 (en) * 1986-10-20 1990-10-12 Centre Nat Rech Scient SUPPORT FOR THE PURIFICATION AND SEPARATION OF PROTEINS, PREPARATION METHOD AND APPLICATION IN CHROMATOGRAPHY
DE3726454A1 (en) * 1987-08-08 1989-02-16 Behringwerke Ag POLYMERS CONTAINING THIOL GROUPS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
DE3889063T2 (en) * 1987-10-30 1994-12-01 American Cyanamid Co Disulfur analogs of LL-E33288 antitumor compounds.
GB2233654A (en) * 1989-07-07 1991-01-16 Nat Res Dev Immobilised polynucleotides

Also Published As

Publication number Publication date
GB2244491A (en) 1991-12-04
AU7563891A (en) 1991-10-30
WO1991015242A1 (en) 1991-10-17
GB9007384D0 (en) 1990-05-30

Similar Documents

Publication Publication Date Title
EP0442073A3 (en) Polycyclic 3-aryl-pyrrolidine-2,4-dione derivatives
AU5329994A (en) Water-absorbent polymer having improved properties
DE69211764D1 (en) Degradable polymer network
HK64297A (en) Polymer compositions
GB2241245B (en) Novel aromatic polysulfoneetherketone polymers
AU8785291A (en) New tricyclic compounds
EP0662123A4 (en) Photoconversion of gasified organic materials into biologically-degradable plastics.
GB9009570D0 (en) Antithrombogenic polymers
ZA916617B (en) Tricyclic compounds
GB9106894D0 (en) Conjugate compounds of polymers with other organic molecular entities
EP0467826A3 (en) Linear polymers
GB9000865D0 (en) Polymer composition
AU8436991A (en) Photogenerated conducting organic polymers
TR25073A (en) PREPARATION OF POLYCETONE POLYMERS.
GB2240548B (en) New polymers
ZA917659B (en) Polymer compositions
AU8628791A (en) Substituted tricyclic compounds
AU6234890A (en) High molecular weight acrylic polymers
GB2248621B (en) Polymer mixture
AU7618991A (en) Novel tricyclic compounds
GB9025770D0 (en) Stabilised polymer composition
EP0485035A3 (en) Preparation of polymers
NO914163D0 (en) POLYMER COMPOUNDS
ZA91313B (en) Propylene-ethylene polymers
EP0466026A3 (en) Biodegradable polymers

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)